Cite
HARVARD Citation
Marron, T. et al. (n.d.). 289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting. Journal for immunotherapy of cancer. p. A177. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Marron, T. et al. (n.d.). 289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting. Journal for immunotherapy of cancer. p. A177. [Online].